Signet Healthcare Partners

What Signet Healthcare Partners does

Signet Healthcare Partners is a New York-based private growth equity firm founded in 1998 that provides growth capital to commercial-stage healthcare companies, with a stated focus on the pharmaceutical and medical device sectors. Over its 25+ year history, the firm has raised cumulative capital commitments exceeding $600 million across multiple fund vehicles and invested in more than 60 companies spanning pharmaceutical services (CDMOs, specialty generic manufacturers, viral vector production), medical devices (organ transport, interventional pain, endoscopy), and biologics. Its portfolio includes current holdings such as RK Pharma, NorthX Biologics, PainTEQ, Curida, LAXAI, Juno Pharmaceuticals, Ascendia Pharmaceuticals, and GBI, plus realized investments including Paragonix Technologies (acquired by Getinge, September 2024), Pharmaceutics International/Pii (acquired by Jabil, February 2025), Vigene Biosciences (acquired by Charles River Laboratories for up to $350 million), and CoreRx (sold to NovaQuest).

The firm operates a lean investment model, with 1-10 employees, deploying approximately $20 million per transaction through Fund V, typically taking active minority positions in portfolio companies. Signet partners closely with management teams, securing board seats and operating involvement; Managing Directors James Gale (Founder), Ashley Friedman, and Nikhil Puri each hold multiple portfolio company board seats. The firm sources deals through direct outreach, healthcare industry networks, co-investor relationships (Windham Capital Partners, MVolution Partners, Flerie AB, Canica, Investinor, Klaveness, Farvatn), and participation in healthcare-focused investment conferences.

Signet's revenue mechanics follow standard private equity economics: recurring management fees on committed capital under management, supplemented by carried interest and performance fees on successful portfolio exits. Fee structures and LP composition are not publicly disclosed. The firm is privately held with no parent company or subsidiaries, is incorporated in New York under U.S. law, and maintains its principal office at Carnegie Hall Tower, 152 West 57th Street, 59th Floor, New York, NY 10019. Operating geographies span North America (USA, Canada), Europe (Sweden, Norway, Germany, Denmark, Netherlands), and Asia (India, Israel).

Name

Signet Healthcare Partners

Legal name

Signet Healthcare Partners

Website

https://signethealthcarepartners.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

1–10 employees

Short description

Signet Healthcare Partners is a New York-based private growth equity firm founded in 1998 that invests growth capital in commercial-stage healthcare companies, primarily pharmaceutical services and medical device businesses, having raised over $600 million and invested in 60+ companies.

Ownership category

akta.pro rank

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Fund Management Fees: Signet generates revenue through management fees charged on the funds under management, typically calculated as a percentage of committed capital or assets under management.
2. Carried Interest/Performance Fees: The firm earns carried interest (carry) on investment returns from successful portfolio company exits, representing a significant portion of private equity fund economics.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Signet Healthcare Partners is a private growth equity firm that provides growth capital to commercial-stage healthcare companies in the pharmaceutical and medical device sectors, typically deploying approximately $20–25 million per transaction through Fund V in active minority positions. The firm partners closely with management teams, taking board seats and providing strategic guidance, operational support, and access to its healthcare industry network alongside capital. Beyond direct investments, Signet also manages pooled capital on behalf of institutional limited partners through successive fund vehicles.

Product overview

Signet Healthcare Partners is a healthcare growth equity firm that provides growth capital investment services to innovative commercial-stage healthcare companies. The firm does not offer a unified product platform but rather provides capital, strategic guidance, and deep industry networks to its portfolio companies. Signet's portfolio spans pharmaceutical services (CDMOs, generic pharmaceutical companies), medical device companies (organ preservation, interventional pain management, endoscopy), and biotech companies across North America, Europe, and Asia. The firm's investment strategy focuses on the pharmaceutical and medical device sectors, supporting companies from pre-commercial launch through growth phases.

Differentiator

Problem solved

Functional benefit

Products and services

• Growth Capital Investment Services

Quantifiable outcome

• Revenue nearly quadrupled over four years for RK Pharma under Signet's investment
• +1 more outcomes

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Ampersand Capital Partners: Healthcare and life sciences-focused growth equity firm specializing in pharma services, CDMOs, and life science tools. Closely comparable to Signet in sector focus, check size, and minority/active growth investment strategy.
• Linden Capital Partners: Healthcare-dedicated middle-market private equity firm focused on pharma services, medical products, and healthcare services. Highly comparable to Signet in sector specialization and middle-market growth equity approach.
• EW Healthcare Partners: Healthcare-focused growth equity firm (formerly Essex Woodlands) investing in commercial-stage healthcare companies across pharma services, medical devices, and specialty pharma. Direct competitor for similar growth-stage healthcare deals.
• Health Enterprise Partners: Growth equity firm focused exclusively on healthcare services, pharma services, and healthcare technology companies. Comparable middle-market healthcare growth equity mandate and check size to Signet.
• Avista Capital Partners: Healthcare-focused private equity firm investing in pharmaceutical services, medical devices, and healthcare technology. Overlapping investment thesis and target company profiles with Signet.
• OrbiMed: Healthcare-dedicated investment firm across venture, growth equity, and buyout stages. Heavily overlapping in pharma services, CDMO, and medical device investments with Signet, though typically at larger scale.

Broad incumbents

• Welsh, Carson, Anderson & Stowe: Large healthcare-focused PE firm with dedicated healthcare practice investing across services, pharma services, and medical devices. Comparable sector focus but at materially larger fund size than Signet.
• KKR Health Care Strategic Growth: Growth equity fund within KKR focused on healthcare. Competes for similar commercial-stage healthcare growth deals but with significantly larger fund size and broader platform capabilities.
• TPG Capital (Healthcare): Major private equity firm with significant healthcare practice investing across pharma services, devices, and healthcare services. Overlaps with Signet on growth-stage healthcare investments but operates at much larger scale.
• NovaQuest Private Equity: Private equity firm with healthcare specialization that acquired Signet's CoreRx portfolio company. Operates overlapping investment thesis in pharma services/CDMOs with broader investment mandate including structured financing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments25 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Signet Healthcare Partners